Publication | Closed Access
Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose
40
Citations
9
References
2011
Year
Efficacious Clinical DoseHuman PharmacokineticsMedicineImmunologyTherapeutic EfficacyPreclinical PharmacokineticsPharmacotherapyAntibody EngineeringPharmacologyNovel TherapyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1